Terumo (OTCMKTS:TRUMY) Shares Gap Up – Still a Buy?

Terumo Corp. (OTCMKTS:TRUMYGet Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.39, but opened at $12.80. Terumo shares last traded at $12.79, with a volume of 41,690 shares traded.

Analyst Ratings Changes

Separately, Nomura upgraded Terumo to a “hold” rating in a research report on Tuesday, February 24th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Get Our Latest Stock Report on TRUMY

Terumo Price Performance

The company has a fifty day simple moving average of $13.61 and a 200-day simple moving average of $15.42. The company has a market cap of $18.87 billion, a P/E ratio of 22.05 and a beta of 0.74. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.51 and a quick ratio of 1.46.

Terumo (OTCMKTS:TRUMYGet Free Report) last issued its earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The company had revenue of $1.94 billion during the quarter, compared to analyst estimates of $1.82 billion. Terumo had a return on equity of 9.13% and a net margin of 11.74%.

About Terumo

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

Featured Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.